Results 11 to 20 of about 1,085,795 (289)
Therapies for Chronic Allograft Rejection
Frontiers in Pharmacology, 2021 Remarkable advances have been made in the pathophysiology, diagnosis, and treatment of antibody-mediated rejection (ABMR) over the past decades, leading to improved graft outcomes.
Min Young Kim, Daniel C. Brennan
doaj +1 more source
Frontiers in Immunology, 2021 Predicted Indirectly ReCognizable Human Leukocyte Antigen (HLA) Epitopes (PIRCHE) are known to be a significant risk factor for the development of donor HLA-specific antibodies after organ transplantation.
Matthias Niemann +8 more
doaj +1 more source
The Journal of Experimental Medicine, 1963 Injection of a sufficient dose of bacteriophage ϕX 174 into guinea pigs results in the formation of rapidly sedimenting antibody molecules (19S), and later, slowly sedimenting molecules (7S). Above a threshold dose of antigen, the relative rate of 19S formation is maximal and dose-independent; below this dose, slower relative rates are obtained.
Martin S Finkelstein, Jonathan W Uhr
openaire +1 more source
The Journal of Experimental Medicine, 1962 Injection of a small bacteriophage ϕX 174 into guinea pigs results in an accelerated elimination of phage detectable as early as 24 hours after injection. The immune nature of the accelerated elimination is indicated by its specificity, by the appearance of excess specific serum antibody after phage elimination, and by the prevention of accelerated ...
Jonathan W. Uhr +2 more
openaire +1 more source
The Journal of Experimental Medicine, 1961 The suppression of antibody formation by passively administered antibody is influenced by the dose and nature of the antigen, type of immunization procedure, ratio of antibody to antigen, species origin and characteristics of the antiserum used, as well as the species selected for immunization.
Jonathan W. Uhr, Joyce B. Baumann
openaire +2 more sources
Vaccines, 2022 The COVID-19 pandemic continues to be a worldwide health issue. Among hemodialysis (HD) patients, two-dose immunization schemes with mRNA vaccines have contributed to preventing severe COVID-19 cases; however, some have not produced a sufficient humoral ...
José Jesús Broseta +5 more
doaj +1 more source
Measles vaccination in children with neurological disorders
Журнал инфектологии, 2014 The data on the current vaccination process and specific antibody in 212 children with pathology of nervous systems in age from 1 year to 6 years old, vaccinated against measles. The comparison group consisted of 36 children without neurological disease.
S. P. Kaplina +3 more
doaj +1 more source
Frontiers in Immunology, 2017 The initiation, commitment, and terminal differentiation of the B cell lineage is stringently controlled by the coordinated action of various transcription factors.
Katrin Habir +3 more
doaj +1 more source
Prevalência de aloimunização eritrocitária em pacientes portadores de anemia falciforme
ABCS Health Sciences, 2017 Embora as transfusões de concentrado de hemácias sejam importantes para o tratamento de pacientes com anemia falciforme, elas acarretam riscos imunológicos tais como a aloimunização a antígenos eritrocitários.
Alexandre Gomes Vizzoni +1 more
doaj +1 more source
Arthritis Research & Therapy, 2022 Background Neutrophil extracellular traps (NETs) are critically involved in microscopic polyangiitis (MPA) pathogenesis, and some patients with MPA possess anti-NET antibody (ANETA). Anti-myosin light chain 6 (MYL6) antibody is an ANETA that affects NETs.
Miku Yoshinari +15 more
doaj +1 more source